ANDA User Fees Will Fund Public Relations-focused Studies On Palatability Of Generics
Executive Summary
One project will look at tablet size, odor and other characteristics that in the past have been a source of public complaints about generics.
You may also be interested in...
Generic Pills Allowed Limited Size Differential In Draft Guidance
FDA cites concern about safety and patient adherence to therapy in draft guidance on the size, shape and other physical attributes of generic drugs.
FDA’s Generic Regulatory Science Plan Taking Broad-brush Approach So Far
Agency lists five topics for industry and stakeholders to focus on during a June 21 meeting on what its fiscal year 2014 priorities should be; among issues for consideration are prioritizing projects based on public health impact and identifying challenges that limit the availability of generic drugs.
GDUFA: FDA Sees High Fee Collection Rate After First Six Months
About 24% of facility fees and 20% of all fees are outstanding, but industry officials also want to measure success through FDA hiring and communication.